Sunday - July 13, 2025
Wistar Scientists Find FDA-Approved Drug Halts EBV-Driven Lymphoma by Disrupting a Key Cancer Pathway
July 11, 2025
PHILADELPHIA, Pennsylvania, July 11 (TNSjou) -- The Wistar Institute issued the following news release on July 10, 2025:

* * *

Wistar Scientists Find FDA-Approved Drug Halts EBV-Driven Lymphoma by Disrupting a Key Cancer Pathway

PHILADELPHIA -- (July 10, 2025) -- Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products